|
JUNE 2011 Gene-Related Patents Issued - Full patent |
|||||
|
CHEMICAL APPARATUS |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,964,139 |
Microfluidic rotary flow reactor matrix |
California Institute of Technology |
21-Jun-11 |
United States |
|
|
|
|||||
|
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,968,283 |
Gene expressed in prostate cancer |
Agensys, Inc. |
28-Jun-11 |
United States |
|
|
7,960,104 |
Self-assembled single molecule arrays and uses thereof |
Callida Genomics, Inc. |
7-Jun-11 |
United States |
|
|
7,968,336 |
Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
Children's Medical Center Corporation |
28-Jun-11 |
United States |
|
|
7,955,823 |
Microorganism producing glutamic acid in high yield and a process of producing glutamic acid using the same |
CJ CheilJedang Corporation |
7-Jun-11 |
Korea |
|
|
7,968,333 |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
Cold Genesys, Inc. |
28-Jun-11 |
United States |
|
|
7,968,286 |
Settings for recombinant adenoviral-based vaccines |
Crucell Holland B.V. |
28-Jun-11 |
Netherlands |
|
|
7,964,383 |
Perhydrolase providing improved peracid stability |
E. I. du Pont de Nemours and Company |
21-Jun-11 |
United States |
|
|
7,960,151 |
Perhydrolase providing improved peracid stability |
E.I. du Pont de Nemours and Company |
7-Jun-11 |
United States |
|
|
7,960,118 |
EGFR mutations |
Genentech, Inc. |
7-Jun-11 |
United States |
|
|
7,960,107 |
Method of determining the susceptibility of a subject to developing insulin-dependent diabetes |
Institut Pasteur |
7-Jun-11 |
France |
|
|
7,964,393 |
Constitutive promoter Lip3 |
Korean Rural Development Administration |
21-Jun-11 |
Korea |
|
|
7,964,401 |
Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3 |
Kyoto University |
21-Jun-11 |
Japan |
|
|
7,964,341 |
Human endogenous retrovirus K102 with foamy-virus-like properties and uses thereof |
Laderoute; Marian |
21-Jun-11 |
Canada |
|
|
7,968,287 |
In vitro evolution in microfluidic systems |
Medical Research Council Harvard University |
28-Jun-11 |
United States |
|
|
7,964,367 |
Human p51 genes and gene products thereof |
Otsuka Pharmaceutical Co., Ltd. |
21-Jun-11 |
Japan |
|
|
7,955,796 |
Method for the direct detection of methicillin-resistant staphylococcus aureus |
Schrenzel; Jacques |
7-Jun-11 |
Switzerland |
|
|
7,960,114 |
Gene signature of early hypoxia to predict patient survival |
Siemens Medical Solutions USA, Inc. |
7-Jun-11 |
United States |
|
|
7,955,844 |
Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals |
Stanford University |
7-Jun-11 |
United States |
|
|
7,968,290 |
Method of detecting gene |
Sumitomo Bakelite Co., Ltd. |
28-Jun-11 |
Japan |
|
|
7,964,349 |
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
The General Hospital Corporation |
21-Jun-11 |
United States |
|
|
7,964,358 |
Sphingosine 1-phosphate receptor gene, SPPR |
University of South Florida |
21-Jun-11 |
United States |
|
|
7,960,147 |
Quantitative measurement of gene expression based on isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
University of Southern California |
7-Jun-11 |
United States |
|
|
|
|||||
|
COATING PROCESSES |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,955,639 |
System and method for loading a beneficial agent into a medical device |
Innovational Holdings, LLC. |
7-Jun-11 |
United States |
|
|
|
|||||
|
DATA PROCESSING |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,962,291 |
Methods and computer software for detecting splice variants |
Affymetrix, Inc. |
7-Jun-11 |
United States |
|
|
7,957,908 |
System, method and software arrangement utilizing a multi-strip procedure that can be applied to gene characterization using DNA-array data |
New York University |
7-Jun-11 |
United States |
|
|
7,957,909 |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
Source Precision Medicine, Inc. |
7-Jun-11 |
United States |
|
|
|
|||||
|
DRUG |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,959,930 |
Rescue of influenza virus |
Abbott Biologicals B.V. |
7-Jun-11 |
Netherlands |
|
|
7,968,106 |
ABFB-1 gene of penicillium funiculosum |
Adisseo France S.A.S. |
28-Jun-11 |
France |
|
|
7,968,090 |
Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer |
Agensys, Inc. |
28-Jun-11 |
United States |
|
|
7,968,099 |
Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
Agensys, Inc. |
28-Jun-11 |
United States |
|
|
7,964,617 |
Methods for treating parkinsons disease and parkinsonism |
Amicus Therapeutics, Inc. |
21-Jun-11 |
United States |
|
|
7,959,932 |
Human rotavirus and vaccine composition comprising same |
Chung-Ang University Industry Academic Cooperation Foundation |
7-Jun-11 |
Korea |
|
|
7,968,087 |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
Crucell Holland B.V. |
28-Jun-11 |
Netherlands |
|
|
7,964,571 |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
Egen, Inc. |
21-Jun-11 |
United States |
|
|
7,955,600 |
Attenuated salmonella SP12 mutants as antigen carriers |
Emergent Product Development UK Limited |
7-Jun-11 |
United Kingdom |
|
|
7,968,526 |
Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer |
Lorus Therapeutics Inc. |
28-Jun-11 |
Canada |
|
|
7,955,596 |
B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
New York University |
7-Jun-11 |
United States |
|
|
7,968,102 |
Dengue chimeric viruses |
Sanofi Pasteur S.A. |
28-Jun-11 |
France |
|
|
7,964,573 |
Regulating expression of transient receptor potential channel genes |
The Regents of the University of California |
21-Jun-11 |
United States |
|
|
7,964,575 |
Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer |
Universite Libre de Bruxelles |
21-Jun-11 |
Belgium |
|
|
|
|||||
|
FOOD OR EDIBLE MATERIAL |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,968,139 |
Packaged beverages |
Kao Corporation |
28-Jun-11 |
United States |
|
|
|
|||||
|
MULTICELLULAR LIVING ORGANISMS |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,964,771 |
Transplastomic plants free of the selectable marker gene |
Bayer Crop Science AG |
21-Jun-11 |
France |
|
|
7,960,605 |
Methods for testing for caloric restriction (CR) mimetics |
BioMaker Pharmaceuticals, Inc. |
7-Jun-11 |
United States |
|
|
7,968,766 |
Plant UDP-galatose epimerases |
E.I. du Pont de Nemours and Company |
28-Jun-11 |
United States |
|
|
7,956,237 |
Gene disruptions, compositions and methods relating thereto |
Genentech, Inc. |
7-Jun-11 |
United States |
|
|
7,960,611 |
Method for promoting efficiency of gene introduction into plant cells |
Japan Tobacco Inc. |
7-Jun-11 |
Japan |
|
|
7,968,764 |
Methods for increasing the yield of fermentable sugars from plant stover |
Purdue Research Foundation |
28-Jun-11 |
United States |
|
|
7,960,606 |
Mouse model of chronic heart failure and coronary atherosclerosis regression |
The J. David Gladstone Institutes |
7-Jun-11 |
United States |
|
|
7,968,762 |
Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF) |
Van Andel Research Institute |
28-Jun-11 |
United States |
|
|
|
|||||
|
NATURAL RESINS OR DERIVATIVES |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,964,700 |
Inhibitors of Taspase1 protease activity |
Dana-Farber Cancer Institute, Inc. |
21-Jun-11 |
United States |
|
|
7,968,676 |
Tumor antigen protein SART-3 and tumor antigen peptides thereof |
Green Peptide Co., Ltd. |
28-Jun-11 |
Japan |
|
|
7,968,688 |
Antibodies that bind to the C35 polypeptide |
University of Rochester |
28-Jun-11 |
United States |
|
|
|
|||||
|
ORGANIC COMPOUNDS |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,960,527 |
Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
Agensys, Inc. |
7-Jun-11 |
United States |
|
|
7,964,709 |
Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA |
Ajinomoto Co., Inc. |
21-Jun-11 |
Japan |
|
|
7,956,177 |
dsRNA compositions and methods for treating HPV infection |
Alnylam Pharmaceuticals, Inc. |
7-Jun-11 |
United States |
|
|
7,964,710 |
EML4-ALK fusion gene |
Astellas Pharma Inc |
21-Jun-11 |
Japan |
|
|
7,968,691 |
Pullulanase variants with increased productivity |
Danisco US Inc. |
28-Jun-11 |
United States |
|
|
7,960,528 |
Perhydrolase providing improved peracid stability |
E. I. du Pont de Nemours and Company |
7-Jun-11 |
United States |
|
|
7,960,536 |
Synthetic cell-or tissue-specific transcriptional regulatory regions |
Genetronics, Inc. |
7-Jun-11 |
United States |
|
|
7,956,178 |
RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA) |
McSwiggen; James |
7-Jun-11 |
United States |
|
|
7,964,714 |
Gene expression suppression agents |
Potomac Pharmaceuticals Inc. |
21-Jun-11 |
United States |
|
|
7,956,176 |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
Sirna Therapeutics, Inc. |
7-Jun-11 |
United States |
|
|
7,960,525 |
Gene repair involving in vivo excision of targeting DNA |
The Children's Medical Center Corporation |
7-Jun-11 |
United States |
|
|
7,968,698 |
Optimized core promoters and uses thereof |
The Regents of the University of California |
28-Jun-11 |
United States |
|
|
7,960,535 |
Recombinant lipidated PsaA protein, methods of preparation and use |
The United States of America as represented by the Department of Health and Human Services |
7-Jun-11 |
United States |
|
|
7,960,541 |
Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
The University of Western Australia |
7-Jun-11 |
Australia |
|
|
|
|||||
|
SURGERY |
|||||
|
Pat No |
Title |
Assignee |
Date Issued |
Country |
|
|
7,963,956 |
Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
Antisense Pharma GmbH |
21-Jun-11 |
Germany |
|
|
7,955,296 |
Biologically enhanced irrigants |
NuOrtho Surgical, Inc. |
7-Jun-11 |
United States |
|
Login
Advertisements
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact wdayal@dayalresources.com
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.





